Back

Molecular determinants of right ventricular diastolic dysfunction: stratifying evidence from validated to inferred mechanisms

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Heart failure diagnostic, biomarkers, and monitoring Diastolic Ventricular Dysfunction ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor James Healy

St Vincents Hospital, Sydney (Australia)

6 More presentations in this session

Presentation thumbnail
Left atrioventricular coupling Index as a parameter of diastolic dysfunction in type 2 diabetes mellitus
Doctor R. Elhelf (Mansoura, EG)
Abstract Slides Video
Presentation thumbnail
Prognostic value of longitudinal ventricular strain changes in a contemporary cohort of muscular dystrophy
Doctor M. Boi (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Comparison of the 2016 and 2025 ASE/EACVI Guidelines for assessing diastolic dysfunction in patients with preserved left ventricular ejection fraction
Miss W. Hu (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Exercise capacity in arterial hypertension: left ventricular posterior wall thickness as a structural determinant of reduced peak oxygen consumption in preserved ejection fraction phenotype
Ms V. Pires Kassab (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Myocardial work index for predicting left ventricular ejection fraction change in patients with left bundle branch block
Professor G. Cho (Seongnam, KR)

Access the full session

Session thumbnail
Heart failure diagnostic, biomarkers, and monitoring

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Mavacamten improves left ventricular systolic synchrony in obstructive hypertrophic cardiomyopathy: real-world data from China
29 August 2026
thumbnail
Congress Session
The imager’s roadmap to evaluation of the right ventricle
11 December 2024
thumbnail
Congress Presentation
Late-systolic apical suction and early-diastolic driving force in ischemic heart disease with left ventricular aneurysm: vector flow mapping with invasive validation
28 August 2026
thumbnail
Congress Presentation
Targeting fibroblast CTHRC1 ameliorates cardiac fibrosis and dysfunction by suppressing cardiomyocyte NLRP3 inflammasome activation
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources